Fish oil and the management of hypertriglyceridemia

Nutrition and Health

Volumn 20, Issue 1, 2009, Pages 41-49

  Mattar, Melanie ^a   Obeid, Omar ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

DHA; EPA; Hypertriglyceridemia; Omega 3 fatty acids; Triglycerides

Indexed keywords

EID: 62149099518     PISSN: 02601060     EISSN: None     Source Type: Journal    
DOI: 10.1177/026010600902000105     Document Type: Article

References (39)

1. Aligeti, V.R., Gandhi, M., Braden, R., Rezk, A., Elam, M.B. (2007). Effect of Combination Lipid-Modifying Therapy on the Triglyceride Lowering Effect of Fish oil. Am J Med Sci. 333(3), 168-172.
2. Al-Lawati, J.A., Mohammed, AJ, Al-Hinai, H.Q. and Jousilahti, P. (2003). Prevalence of the Metabolic Syndrome Among Omani Adults. Diabetes Care. 26, 1781-1785.
3. Al-Nozha, M., Al-Khadra, A., Arafah, M.R., Al-Maatouq, M.A., Khalil, M.Z., Khan, N.B., Al-Mazrou, Y.Y., Al-Marzouki, K., Al-Harthi, S.S., Abdullah, M., Al-Shahid, M.S., Al-Mobeireek, A., Nouh, M.S. (2005). Metabolic Syndrome in Saudi Arabia. Saudi Med J. 26(12), 1918-25.
4. Bouguerra, R., Ben Salema, L., Albertib, H., Ben Rayanaa, C., El Attia, J., Blouzaa, S., Gaigia, S., Achoura, A., Ben Slamaa, C. and Zouari, B. (2006). Prevalence of metabolic abnormalities in the Tunisian adults: a population based study. Diabetes & Metabolism. 32(3), 215-221.
5. Buckley, R., Shewring, B., Turner, R., Yaqoob, P., Minihane, A.M. (2004). Circulating triacylglycerol and ApoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects. British Journal of Nutrition. 92, 477-483.
6. Connor, W.E. (2000). Importance of n-3 fatty acids in health and disease. Am J Clin Nutr. 71(1), 171S-175S.
7. Dallongeville, J., Lussier-Cacun, S., Davignon, J. (1992). Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res. 33, 447-454.
8. Damsgaard, C.T., Frøkiaer, H., Anderson, A.D., Lauritzen, L. (2008). Fish oil in Combiation with High or Low Intakes of Linoleic Acid Lowers Plasma Triacylglycerols but Does Not Affect Other Cardiovascular Risk Markers in Healthy Men. J. Nutr. 138, 1061-1066.
9. Davidson, M.H. (2006). Mechanisms for the Hypotriglyceridemic Effect of Marine Omega-3 Fatty Acids. Am J Cardiol. 98, 27i-33i.
10. Durrington P.N., Bhatnagar D., Mackness M.I., Morgan, J., Julier, K., Khan, M., France, M. (2001). An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridemia. Heart. 85(5), 544-48.
11. Ebbesson, S.O.E, Tejero, M.E., Nobmann, E.D., Lopez-Alvarenga, J.C., Ebbesson, L.P, Romenesko, T., Carter, E.A., Resnick, H.E., Devereux, R.B., MacCluer, J.W., Dyke, B., Laston, S.L., Wenger, C.R., Fabsitz, R.R., Comuzzie, A.G., Howard B.V. (2007). Fatty Acid Consumption and Metabolic Syndrome Components: The GOCADAN Study. JCMS. 2, 244-49.
12. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel in Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation 2002, 106: 3143-421.
13. Fasching, P., Rohac, M., Liener, K., Schneider, B., Nowotny, P., Waldhäusl, W. (1996). Fish Oil Supplementation versus Gemfibrozil Treatment in Hyperlipidemic NIDDM. A Randomized Crossover Study. Horm Metab Res. 28, 230-236.
14. GISSI-Prevenzione Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI trial. Lancet 7, 447-55.
15. Gochfeld, M. (2003). Cases of mercury exposure, bioavailability, and absorption. Ecotoxicology and Environmental Safety. 56, 174-179.
16. Goyens, P.L.L., Spilker, M.E., Zock, P.L., Katan, M.B., Mensink, R.P. (2006). Conversion of α-linolenic acid in humans is influenced by the absolute amounts of α-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr. 84, 44-53.
17. Harel, Z., Riggs, S., Vaz, R., White, L. and Menzies, G. (2001). Omega-3 polyunsaturated fatty acids in adolescents: knowledge and consumption. J Adolesc Health. 28, 10-15.
18. Harris, W.S. (1997). n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 65(5), 1645S-1654S.
19. Harris, W.S., Miller, M., Tighe, A.P., Davidson, M.H., Schaefer, E.J. (2008). Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives. Atherosclerosis. 197, 12-24.
20. Indu, M. Ghafoorunissa (1992) n-3 Fatty acid in Indian diets- comparison of the effect of precursor (alpha-linolenic acid) v's product (long chain n-3 polyunsaturated fatty acids). Nutr Res. 12, 569-82.
21. Khader, Y., Bateiha, A., El-Khateeb, M., Al-Shaikh, A. and Ajlouni K. (2007). High prevalence of the metabolic syndrome among Northern Jordanians. Journal of Diabetes and its Complications. 21, 214-219.
22. Kris-Etherton, P.M., Taylor, D.S., Yu-Poth, S., Huth, P., Moriarty, K., Fishell, V., Hargrove, R.L., Zhao, G., Etherton, T.D. (2000). Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr. 71, 179S-188S.
23. Kris-Etherton, P.M., Harris, W.S., Appel, L.J. (2002). Fish consumption, Fish Oil, Omeag-3 Fatty Acids, and Cardiovascular Disease. Circulation, 106, 2747-2757.
24. Lauritzen, L., Hansen, H.S., Jorgensen, M.H., Michaelsen, K.F. (2001). The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res, 40, 1-94.
25. McKenney, J.M. and Sica, D. (2007). Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia. Am J Health-Syst Pharm. 64, 595-605.
26. McLaughlin, J., Middaughb, J., Boudreau, D., Malcomc, G., Parry, S., Tracy, R. Newmanc, W. (2005). Adipose tissue triglyceride fatty acids and atherosclerosis in Alaska Natives and non-Natives. Atherosclerosis, 181, 353-362.
27. Minihane, A.M., Khan, S., Leigh-Firbank, E.G., Talmud, P., Wright, J.W., Murphy, M.C., Griffin, B.A., Williams, C.M. (2000). ApoE Polymorphism and Fish Oil Supplementation in Subjects With an Atherogenic Lipoprotein Phenotype. Arterioscler. Thromb. Vasc. Biol. 20(8), 1990-1997.
28. Moore, C.S., Bryant, S.P., Mishra, G.D., Krebs, J.D., Browning, L. M., Miller, G.J., Jebb, S.A. (2006). Oily fish reduces plasma triacylglycerols: a primary prevention study in overweight men and women. Nutrition. 22, 1012-1024.
29. Mori, T.A., Burke, V., Puddey, I. B., Watts, G.F., O'Neal, D.N., Best, J.D., Beilin, L.J. (2000). Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr. 71, 1085-94.
30. Pawlosky, R.J., Hibbeln, J.R., Novotny, J.A., Norman, S. (2001). Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. Journal of Lipid Research. 42, 1257-1265.
31. Pejic, R.N. and Lee, D.T. (2006). Hypertriglyceridemia. J Am Board Fam Med. 19(3), 310-316.
32. Sanders, T.A.B., Roshanai F. (1983). The influence of different types of co-3 polyunsaturated fatty acids on blood lipids and platelet function in healthy volunteers. Clin Sci. 64, 91-9.
33. Scientific Advisory Committee on Nutrition (SACN) Committee on Toxicity. (2004). Advice on fish consumption: benefits and risks. TSO.
34. Sibai A-M., Obeid, O., Batal, M., Adra, N., Khoury, D., Hwalla, N. (2008). Prevalence and correlates of metabolic syndrome in an adult Lebanese population. CVD Prevention and Control. 3, 83-90.
35. Singh, P.P., Singh, M., Mastana, S.S. (2006). ApoE distribution in world populations with new data from India and the UK. Ann. Hum. biol. 33(3), 279-308.
36. Sorkhou, E.I., Al-Qallaf, B., Al-Namash, H.A., Ben-Nakhi, A., Al-Batish, M.M., Habiba, S.A. (2004). Prevalence of Metabolic Syndrome among Hypertensive Patients Attending a Primary Care Clinic in Kuwait. Med Princ Pract. 13, 39-42.
37. Suzukawa, M., Abbey, M., Howe, P.R.C., Nestel, P.J. (1995). Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J. Lipid Res. 36, 473-484.
38. Witztum, J.L., and Steinberg, D. (1991). Role of oxidized low density lipoprotein in atherogenesis. J Clin. Invest. 88, 1785-1792.
39. Yuan, G., Al-Shali, K.Z., Hegele, R.A. (2007). Hypertriglyceridmia: its etiology, effects and treatment. CMAJ. 176(8), 1113-1120.